{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T04:09:41Z","timestamp":1775880581880,"version":"3.50.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,3,1]],"date-time":"2013-03-01T00:00:00Z","timestamp":1362096000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["SEMERGEN - Medicina de Familia"],"published-print":{"date-parts":[[2013,3]]},"DOI":"10.1016\/j.semerg.2012.05.011","type":"journal-article","created":{"date-parts":[[2012,9,5]],"date-time":"2012-09-05T04:16:01Z","timestamp":1346818561000},"page":"77-84","source":"Crossref","is-referenced-by-count":4,"title":["An\u00e1lisis coste-eficacia de los antihipertensivos en dosis fijas"],"prefix":"10.1016","volume":"39","author":[{"given":"A.J.","family":"Garc\u00eda Ruiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.A.","family":"Divis\u00f3n Garrote","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Garc\u00eda-Agua Soler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Morata Garc\u00eda de la Puerta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.C.","family":"Montesinos G\u00e1lvez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"\u00c1vila Lachica","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semerg.2012.05.011_bib0005","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0140-6736(05)70151-3","article-title":"Global burden of hypertension: analysis of worldwide data","volume":"365","author":"Kearney","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.semerg.2012.05.011_bib0010","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1161\/CIRCULATIONAHA.108.191259","article-title":"Heart disease and stroke statistics\u20132009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"119","author":"Lloyd-Jones","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.semerg.2012.05.011_bib0015","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/HJR.0b013e3281764429","article-title":"Trends in cardiovascular risk factors prevalence (1995-2000-2005) in northeastern Spain","volume":"14","author":"Grau","year":"2007","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/j.semerg.2012.05.011_bib0020","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1157\/13074389","article-title":"Factores de riesgo cardiovascular en la poblaci\u00f3n espa\u00f1ola: metaan\u00e1lisis de estudios transversales","volume":"124","author":"Medrano","year":"2005","journal-title":"Med Clin"},{"key":"10.1016\/j.semerg.2012.05.011_bib0025","first-page":"277","article-title":"Evoluci\u00f3n de la prevalencia de los factores de riesgo y del riesgo cardiovascular global en poblaci\u00f3n mayor de 18 a\u00f1os de la provincia de Albacete (1992-94 a 2004-2006)","volume":"85","author":"Divis\u00f3n","year":"2011","journal-title":"Rev Esp Salud P\u00fablica"},{"key":"10.1016\/j.semerg.2012.05.011_bib0030","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1097\/00004872-200211000-00014","article-title":"Hypertension magnitude and management in the elderly population of Spain","volume":"20","author":"Banegas","year":"2002","journal-title":"J Hypertens"},{"key":"10.1016\/j.semerg.2012.05.011_bib0035","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.107.183885","volume":"115","author":"Rosendorff","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.semerg.2012.05.011_bib0040","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"25","author":"Guidelines for the management of arterial hypertension.","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/j.semerg.2012.05.011_bib0045","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1097\/HJH.0b013e328333146d","article-title":"Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document","volume":"27","author":"Mancia","year":"2009","journal-title":"J Hypertens"},{"key":"10.1016\/j.semerg.2012.05.011_bib0050","doi-asserted-by":"crossref","unstructured":"American Diabetes Assocation (ADA). Position Statement. Diabetes Care. 2011;34:S1-S102.","DOI":"10.2337\/dc11-S100"},{"key":"10.1016\/j.semerg.2012.05.011_bib0055","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1161\/CIRCULATIONAHA.110.016337","article-title":"Blood pressure targets in subjets with type 2 diabetes mellitus\/impaired fasting glucose. Observacions from traditional and Bayesian random-effects meta-analyses of randomized trials","volume":"123","author":"Bangalore","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.semerg.2012.05.011_bib0060","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0212-8241(05)71587-5","article-title":"Epidemiolog\u00eda de la hipertensi\u00f3n arterial en Espa\u00f1a. Situaci\u00f3n actual y perspectivas","volume":"22","author":"Banegas","year":"2005","journal-title":"Hipertensi\u00f3n"},{"key":"10.1016\/j.semerg.2012.05.011_bib0065","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0212-8241(06)71742-X","article-title":"Estrategias para un control eficaz de la hipertensi\u00f3n arterial en Espa\u00f1a. Documento de Consenso","volume":"23","author":"Coca","year":"2006","journal-title":"Hipertensi\u00f3n"},{"key":"10.1016\/j.semerg.2012.05.011_bib0070","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1157\/13120766","article-title":"Control de la presi\u00f3n arterial en la poblaci\u00f3n hipertensa espa\u00f1ola atendida en atenci\u00f3n primaria. Estudio PRESCAP 2006","volume":"130","author":"Llisterri","year":"2008","journal-title":"Med Clin"},{"key":"10.1016\/j.semerg.2012.05.011_bib0075","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.medcli.2010.01.038","article-title":"Influencia del cumplimiento asociado a la incidencia de eventos cardiovasculares y los costes en combinaciones a dosis fijas en el tratamiento de la hipertensi\u00f3n arterial","volume":"136","author":"Sicras Mainar","year":"2011","journal-title":"Med Clin"},{"key":"10.1016\/j.semerg.2012.05.011_bib0080","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"Benazepril plus amlodipine or hydrochlorotiazide for hypertension in high-risk patients","volume":"359","author":"Jamerson","year":"2008","journal-title":"N Eng J Med"},{"key":"10.1016\/j.semerg.2012.05.011_bib0085","unstructured":"Informaci\u00f3n sobre los productos incluidos en la prestaci\u00f3n farmac\u00e9utica del SNS (dispensables a trav\u00e9s de oficinas de farmacia).[accedido 16 May 2011]. Disponible en: http:\/\/www.msc.es\/profesionales\/farmacia\/frmNomenclator.jsp"},{"key":"10.1016\/j.semerg.2012.05.011_bib0090","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.clinthera.2008.04.002","article-title":"The Combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study","volume":"30","author":"Chrysant","year":"2008","journal-title":"Clinical Therapeutics"},{"key":"10.1016\/j.semerg.2012.05.011_bib0095","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.clinthera.2007.03.018","volume":"29","author":"Philipp","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/j.semerg.2012.05.011_bib0100","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/00151642-200310020-00004","article-title":"Long-term tolerability and efficacy of the fixed combination of manidipine and delapril in patients with Essentials hipertensi\u00f3n","volume":"10","author":"Karpati","year":"2003","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.semerg.2012.05.011_bib0105","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s12325-009-0015-8","article-title":"Fixed-Dose Manidipine\/Delapril versus Losartan\/Hydrochlorothiazide in hypertensive patients with type 3 diabetes and microalbuminuria","volume":"26","author":"Kohlmann","year":"2009","journal-title":"Adv Ther"},{"key":"10.1016\/j.semerg.2012.05.011_bib0110","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s00125-004-1527-z","article-title":"Holman RR on behalf of the UK Prospective Diabetes Study (UKPDS) Group. A model to estimate the lifetime health outcomes of patients with Type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no 68)","volume":"47","author":"Clarke","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/j.semerg.2012.05.011_bib0115","series-title":"Modelos organizativos en la atenci\u00f3n a pacientes con diabetes mellitus tipo 2. Sevilla: Agencia de Evaluaci\u00f3n de Tecnolog\u00edas Sanitarias de Andaluc\u00eda","author":"Garc\u00eda","year":"2009"},{"key":"10.1016\/j.semerg.2012.05.011_bib0120","first-page":"1305","article-title":"Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials","volume":"358","author":"Law","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.semerg.2012.05.011_bib0125","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.amjmed.2006.08.033","article-title":"Fixed-dose combinations improve medication compliance: a meta-analysis","volume":"120","author":"Bangalore","year":"2007","journal-title":"Am J Med"},{"key":"10.1016\/j.semerg.2012.05.011_bib0130","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1157\/13116552","article-title":"Uso racional y eficiente del tratamiento hipocolesterolemiante","volume":"130","author":"Garc\u00eda Ruiz","year":"2008","journal-title":"Med Clin"}],"container-title":["SEMERGEN - Medicina de Familia"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359312001542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1138359312001542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T05:47:44Z","timestamp":1643348864000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1138359312001542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["S1138359312001542"],"URL":"https:\/\/doi.org\/10.1016\/j.semerg.2012.05.011","relation":{},"ISSN":["1138-3593"],"issn-type":[{"value":"1138-3593","type":"print"}],"subject":[],"published":{"date-parts":[[2013,3]]}}}